We serve Chemical Name:(2-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid CAS:1217501-52-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid
CAS.NO:1217501-52-4
Synonyms:2-Methyl-4-(piperidin-1-ylsulfonyl)phenylboronic acid
Molecular Formula:C12H18BNO4S
Molecular Weight:283.15200
HS Code:2935009090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:86.22000
Exact Mass:283.10500
LogP:0.86810
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Methyl-4-(piperidin-1-ylsulfonyl)phenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-4-(piperidin-1-ylsulfonyl)phenylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-4-(piperidin-1-ylsulfonyl)phenylboronic acid Use and application,2-Methyl-4-(piperidin-1-ylsulfonyl)phenylboronic acid technical grade,usp/ep/jp grade.
Related News: Australia has started denying entry to all travelers who have come from or transited through mainland China. (2-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid manufacturer Australia has started denying entry to all travelers who have come from or transited through mainland China. (2-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid supplier Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle �C from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products. (2-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid vendor Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle �C from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products. (2-Methyl-4-(piperidin-1-ylsulfonyl)phenyl)boronic acid factory Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process.
